Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy

• Hauptverfasser: Nazila FATHI MAROUFI (Verfasst von), Amir GHORBANIHAGHJO (Verfasst von), Manizheh SAYYAH MELLI (Verfasst von), Maryam VAEZI (Verfasst von), Zohreh HEKMATI AZAR MEHRABANI (Verfasst von), Maryam BANNAZADEH AMIRKHIZ (Verfasst von), Nadereh RASHTCHIZADEH (Verfasst von)
• Format: Buch
• Veröffentlicht: Tehran University of Medical Sciences, 2017-04-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background: Pregnancy Associated Osteoporosis (PAO) can lead to serious difficulties such as fragility fractures, elongated back pain and height loss in affected women. Soluble Receptor Activator of Nuclear Factor-Kappa B ligand (sRANKL) to Osteoprotegerin (OPG) ratio is chosen as a bone metabolism...